S&P Retreats from Records as Chip Stocks Decline
The S&P 500 and NASDAQ Composite fell on Tuesday, a day after both indexes hit fresh records, as traders weighed the latest earnings reports and new trade developments.The Dow Jones Industrial Average eked higher 13.73 points to 44,336.80.The much-broader index gave back 8.86 points to 6,296.74.The NASDAQ stepped back 94.29 points to 20,879.89.The market was bogged down by a decline in chip stocks, with Broadcom more than 2% lower and artificial intelligence darling Nvidia shedding almost 2%, after The Wall Street Journal reported that SoftBank and OpenAI’s $500-billion AI project has faced difficulties in getting underway, scaling down its near-term plans. Adding to downbeat sentiment in the sector, NXP Semiconductors pulled back more than 1% after the company’s latest quarterly results and guidance disappointed investors.Meanwhile, shares of aerospace and defense name Lockheed Martin were down 8% after the company’s revenue for the second quarter missed analyst estimates. Similarly, Philip Morris lost 8% after the tobacco company’s second-quarter revenue also fell short.This comes as 88 S&P 500 companies have reported, with more than 82% of those topping analysts’ estimates, according to FactSet data. Eyes are on commentary from companies about macroeconomic certainty, the impact of tariffs and details on demand and spending related to AI.Prices for the 10-year treasury climbed, lowering yields to 4.34% from Monday’s 4.38%. Treasury prices and yields move in opposite directions. Oil prices were lower 84 cents to $66.36 U.S. a barrel. Gold prices popped $33.00 to $3,439.40 U.S. an ounce.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


